Coty Inc.

Fundamentals6.0
Price Action6.0
News Sentiment6.0
AI Rating
6.0

Key Drivers

  • High gross margins
  • Improving cashflow
  • Weak liquidity

AI
AI Summary

6.0

Coty's investment thesis has shifted to a balance-sheet-first, fragrance-led turnaround—recent material FCF and leverage reduction create real upside if management delivers two consecutive quarters of EBITDA stabilization and repeatable FCF while selectively scaling premium fragrance wins, but unresolved Gucci/Kering licensing risk, potential impairments, or a FCF reversal remain the primary triggers for a sharp negative re-rating.

CashFlow
Legal
Restructuring‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

6.0

Key Financial Insights:

  • High gross margins
  • Improving cashflow
  • Weak liquidity

COTY combines durable high gross margins and improving free cash flow and deleveraging with persistent net losses, weak short-term liquidity, and a recent collapse in EBITDA that heightens near‑term risk.

CashFlow
Liquidity

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Strong downtrend
  • Below SMA
  • Nearby support

Stock is in a clear short-term downtrend over the last month, falling ~20% to $2.14 and trading ~10% below its last-month SMA, with nearest support at $2.12 and resistance at $2.65–$2.69 requiring a decisive break to reverse the trend.

weak
oversold
Support Level: $2.12
Resistance Level: $2.65–$2.69

~20% decline over the last month to $2.14 indicating strong negative momentum

Sentiment & News

6.0

Key News Insights:

  • Legal investigations
  • Guidance suspended
  • Board overhaul

Coty faces legal probes, a suspended FY'26 guidance and weak Consumer Beauty performance even as sales stabilize, leverage improves and the board is overhauled while management pivots to premium fragrances.

ExecutionRisk
BoardRefresh

Near-term share pressure and execution risk will likely keep valuation under scrutiny, though improved leverage and strategic refocus could support a recovery if execution stabilizes